Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Amer H. Zureikat"'
Autor:
A. Floortje van Oosten, Michael J. Pflüger, Wenjie Huang, Elizabeth D. Thompson, Vincent P. Groot, Steven Gallinger, Sandra Fischer, Limin Xia, Neil M. Neumann, Nicholas J. Roberts, Richard A. Burkhart, Stefan Heinrich, Alina Hasanain, Claudio Luchini, Jin He, Kim-Vy Nguyen-Ngoc, Bernat Navarro-Serer, Anne Macgregor-Das, Laura D. Wood, Maria A. Trujillo, Gemma Lionheart, Andrew J. Ewald, Peter Chianchiano, Michael Goggins, Amer H. Zureikat, Christopher L. Wolfgang, Randall E. Brand, Yea Ji Jeong, Matthias M. Gaida, Cameron Dowiak, Tammy Ng, Aatur D. Singhi, Danielle Jones, Kohei Fujikura, Bo Huang, Nicola Veronese
Publikováno v:
Cancer Res
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by extensive local invasion and systemic spread. In this study, we employed a three-dimensional organoid model of human pancreatic cancer to characterize the molecular
Autor:
Teng-Kuei Hsu, Christine Decapite, Ofer Shapira, Alessandro Paniccia, Chun Yang, Shivani Mahajan, Richard Bourgon, Peter Ulz, Marvin Bertin, Amit Pasupathy, Julie M. Granka, Adam Drake, C. Jimmy Lin, Tzu-Yu Liu, Preet Kaur, Randall E. Brand, Kaitlyn Coil, Maggie C. Louie, Billie Gould, Hayley Donnella, Amer H. Zureikat, Eric A. Ariazi
Publikováno v:
Cancer Research. 81:PO-007
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with an overall five-year survival rate of 11%. Potential curative resection is possible if the tumor is detected at an early stage, with a five-year survival rate of 42%. The o
Autor:
Daniel Barnett, Ying Liu, Brian B. Haab, Ben Staal, Amer H. Zureikat, Ying Huang, Luke Wisniewski, Randall E. Brand, Mohammed Aldakkak, Peter J. Allen, Ian Beddows, Chong-Feng Gao, Dennis Plenker, Douglas B. Evans, Mirna Kheir Gouda, Aatur D. Singhi, Johnathan Hall, Richard R. Drake, Susan Tsai, David A. Tuveson
Publikováno v:
Cancer Research. 80:PO-002
A subset of pancreatic ductal adenocarcinomas (PDACs) is highly resistant to systemic chemotherapy, but no markers are available in clinical settings to identify this subset. In this study, we evaluate the role of sTRA, a glycan biomarker for PDAC, i
Autor:
Ravikumar Muthuswamy, Erik Berk, Beth Fallert Junecko, Herbert J. Zeh, Amer H. Zureikat, Daniel Normolle, The Minh Luong, Todd A. Reinhart, David L. Bartlett, Pawel Kalinski
Publikováno v:
Cancer Research. 72:3735-3743
Tumor infiltration with effector CD8+ T cells (Teff) predicts longer recurrence-free survival in many types of human cancer, illustrating the broad significance of Teff for effective immunosurveillance. Colorectal tumors with reduced accumulation of